Q1 2024 Swedish Orphan Biovitrum AB (publ) Earnings Call Transcript
Ladies and gentlemen, welcome to the Q1 Results 2024 Conference Call and Live Webcast. I am Alice the Chorus Call operator. (Operator Instructions). The conference must not be recorded for publication or broadcast. At this time, it's my pleasure to hand over to Guido Oelkers, CEO. Please go ahead, sir.
()-&
Yes. Thank you so much, and welcome, everybody. And with this having said, let's go straight to the first slide. It's really a pleasure to welcome you today to our Q1 report. And today, I'm -- a forward-looking statement as the usual. Today, I'm joined by Henrik Stenqvist, our Chief Financial Officer; and Lydia Abad-Franch, our Head of R&D and CMO. And in the Q&A session, we will have also Armin Reininger, our Senior Scientific Adviser. Please go to the next slide.
So, I mean, you have seen the results this morning. And the result was excellent from our perspective is plus 30% versus previous year. I think this way even more up
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
